Skip to main content
Premium Trial:

Request an Annual Quote

Oliver Fetzer, J. Craig Venter

Synthetic Genomics has appointed Oliver Fetzer as the company's new CEO, succeeding Co-founder J. Craig Venter, who will remain actively involved in SGI as executive chairman and co-chief scientist. Fetzer, who most recently served as president and CEO of Cerulean Pharma, will also be a member of SGI's board of directors. He also previously held management positions at Cubist Pharmaceuticals including senior VP of corporate development and R&D; senior VP of corporate development and chief business officer; and senior VP of business development.